I thought a lesson was learnt in the post Bond and Connell era, but it appears not to be so. 30 years on and exorbitant ASX executive remunerations are alive and flourishing. In previous years, BB has taken remuneration in the $5-7M range, which was exorbitant but argued by some to be fair...FY20's $31.7M is, in my view, indefensibly off the scale. Beguiling BB has deserted the ship and made a big grab on the way out. Hopefully, looking forward, NST SHs will have a refreshed BOD that is vocal in their support of SHs interests ranking ahead of all others.
In FY22 NST needs to reduce costs, have executive remuneration reviewed and increasing earnings. It is imperative that NST return to fundamentals and improve its PE, or its SP has no upside. The volatility of gold and no diversification increase NSTs risk profile, IMO, and they need a significant profit improvement to counter-balance this.
In FY21 the SP dropped ~$4, and a similar fall in SP could occur in the next 12 months.
- Forums
- ASX - By Stock
- Bon Voyage Beament
I thought a lesson was learnt in the post Bond and Connell era,...
-
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NST (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.79 |
Change
-0.010(0.06%) |
Mkt cap ! $18.15B |
Open | High | Low | Value | Volume |
$15.85 | $15.98 | $15.71 | $52.51M | 3.319M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3804 | $15.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.79 | 55788 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3804 | 15.780 |
1 | 625 | 15.770 |
4 | 70679 | 15.760 |
4 | 21612 | 15.750 |
2 | 109846 | 15.740 |
Price($) | Vol. | No. |
---|---|---|
15.790 | 55788 | 1 |
15.800 | 46018 | 1 |
15.820 | 13154 | 4 |
15.830 | 17081 | 4 |
15.840 | 13036 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
NST (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online